InvestorsHub Logo
icon url

learningcurve2020

12/30/23 11:18 AM

#660277 RE: learningcurve2020 #660240

No replies. Really?
icon url

flipper44

12/30/23 11:28 AM

#660281 RE: learningcurve2020 #660240

Why did you get a bunch more negative reaction bugs for a neutral question?

Must be more bots.

BTW, I have no idea what Les meant by “most of them blockbuster drugs”

Maybe he meant, most of them blockbuster indications.
icon url

SkyLimit2022

12/30/23 11:59 AM

#660290 RE: learningcurve2020 #660240

LC,

Thanks for your posts today!!



I love you! JCI, Kat Charles, and now 15 cancers!

I agree 100%! We need to see the data and we need to see more studies getting started!

I didn’t know about the 15 cancers comment! I was hoping to see trials begin after commercialization—similar to how pembrolizumab has been in perpetual clinical trials for so many years since its original approval.

I’m going to research the “15” comment because that’s a really exciting preview of the larger trials to come!

https://www.jci.org/articles/view/169314

https://clinicaltrials.gov/study/NCT04201873

Combo is King!

Bullish
Bullish